Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition'.

Rinella, Mary E; Narro, Graciela E Castro; Krag, Aleksander; Terrault, Norah; Newsome, Philip N

Rinella, Mary E; Narro, Graciela E Castro; Krag, Aleksander; Terrault, Norah; Newsome, Philip N.

Affiliation

Rinella ME; University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.
Narro GEC; Department of Hepatology and Transplant, Hospital Médica Sur, Mexico City, Mexico; Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Asociación Latinoamericana para el Estudio del Hígado (ALEH), Santiago, Chile.
Krag A; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; European Association for the Study of the Liver (EASL), Geneva, Switzerland. Electronic address: Aleksander.Krag@rsyd.dk.
Terrault N; Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; American Association for the Study of Liver Diseases (AASLD), Alexandria, USA.
Newsome PN; National Institute for Health Research, Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingh

Ann Hepatol ; 29(4): 101178, 2024.

Article in En | MEDLINE | ID: mdl-38944461

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Limits: Humans Language: En Journal: Ann Hepatol / Ann. hepatol / Annals of hepatology Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: México

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google